New Drug Approval: Fda Needs To Enhance Its Oversight Of Drugs Approved On The Basis Of Surrogate Endpoints

Publisher: United States. Government Accountability Office
Coverage: September 23, 2009

Volumes:

GAO-09-866 (2009-09-23)